Módszerek összehasonlítása
Tekintse át a kiválasztott módszereket egymás mellett; az eltérő sorok kiemelve jelennek meg.
| Szűrővizsgálatok értékelése× | Epidemiológiai keresztmetszeti vizsgálat× | |
|---|---|---|
| Tudományterület | Epidemiológia | Epidemiológia |
| Módszercsalád | Process / pipeline | Process / pipeline |
| Keletkezés éve≠ | 1968 (Wilson-Jungner principles); statistical framework developed 1970s–2000s | 1960s (formal codification); widely practiced since mid-20th century |
| Megalkotó≠ | Wilson & Jungner (WHO criteria, 1968); foundational work by Pepe, Altman, and others in statistical test evaluation | Classical epidemiology tradition; systematized by Brian MacMahon and Thomas Pugh (1960s) |
| Típus≠ | Observational diagnostic / epidemiological evaluation design | Observational, descriptive/analytic epidemiological design |
| Alapmű≠ | Wilson, J. M. G., & Jungner, G. (1968). Principles and Practice of Screening for Disease. World Health Organization. Public Health Papers No. 34. link ↗ | Kelsey, J. L., Whittemore, A. S., Evans, A. S., & Thompson, W. D. (1996). Methods in Observational Epidemiology (2nd ed.). Oxford University Press. ISBN: 978-0195080407 |
| Alternatív nevek | screening study, screening performance evaluation, screening accuracy assessment, STE | prevalence study, cross-sectional survey, transversal study, cross-sectional design |
| Kapcsolódó | 6 | 6 |
| Összefoglaló≠ | Screening test evaluation is a systematic epidemiological approach for assessing whether a test or program can accurately and cost-effectively identify individuals with a condition before symptoms appear. It quantifies diagnostic performance metrics — sensitivity, specificity, predictive values, and the ROC curve — and evaluates whether a screening program meets established public health criteria for adoption and harm-benefit balance. | A cross-sectional epidemiological study measures the exposure(s) and outcome(s) of interest simultaneously in a defined population at a single point in time (or over a short period). Because there is no follow-up, it is the most efficient observational design for estimating disease prevalence and for generating hypotheses about associations between risk factors and health outcomes. |
| ScholarGateAdatkészlet ↗ |
|
|